Minerva Neurosciences (NERV) Non-Current Debt (2015 - 2017)

Minerva Neurosciences has reported Non-Current Debt for 3 years, with the latest figure at $1.3 million in Q2 2017.

• For the quarter ending Q2 2017, Non-Current Debt fell 78.69% year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2017 stood at $1.3 million (down 78.69% YoY), and the FY2016 full-year result was $3.8 million, down 54.83% from the prior year.
• Non-Current Debt for Q2 2017 stood at $1.3 million, down from $2.6 million in the prior quarter.
• The five-year high for Non-Current Debt was $9.6 million in Q3 2015, with the low at $1.3 million in Q2 2017.
• Historically, Non-Current Debt has averaged $6.3 million across 3 years, with a median of $6.8 million in 2016.
• Annual changes were most pronounced in 2016 — Non-Current Debt fell 22.74% — and 2017, when it tumbled 78.69%.
• Minerva Neurosciences' Non-Current Debt stood at $8.5 million in 2015, then sank by 54.83% to $3.8 million in 2016, then plunged by 65.47% to $1.3 million in 2017.
• The last three Non-Current Debt figures came in at $1.3 million (Q2 2017), $2.6 million (Q1 2017), and $3.8 million (Q4 2016), per Business Quant data.